drugset / Trial / NCT07326397
Comparison Between Intrathecal Magnesium Sulphate & Dexmedetomidine in DHS
RandomizedParallel-groupTriple-blindOther
Summary
To compare the efficacy and safety of intrathecal dexmedetomidine and magnesium sulphate as adjuvants to 0.5% hyperbaric bupivacaine in patients undergoing elective DHS fixation, focusing on onset and duration of sensory and motor block, hemodynamic stability, and quality of postoperative analgesia.
Timeline
- Start
- 2026-02-01
- Primary completion
- 2027-11-01
- Completion
- 2027-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dexmedetomidine | Other / unclassified | 5 ug | Intrathecal |
| Comparator | Magnesium Sulfate | Other / unclassified | 50 mg | Intrathecal |
| Background | Bupivacaine | Other / unclassified | 0.5 % | — |
| Background | Bupivacaine | Other / unclassified | 2.5 ml | — |
Indications
No indication recorded.